Some experts from highly regarded institutions across the country would disagree. See this peer-reviewed paper for introduction to their reasoning [1].

[1] Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein https://pubmed.ncbi.nlm.nih.gov/33909660/

That's talking about 1-2 sites. The vaccine elicits a response to a dozen or more.

Did you read the paper I linked to (at least the abstract)? It directly contradicts your claims.

Please cite primary sources to support your claim, otherwise it must be regarded as uninformed opinion.

It says:

>Our modeling suggests that SARS-CoV-2 mutants with one or two mildly deleterious mutations are expected to exist in high numbers due to neutral genetic variation, and consequently resistance to vaccines or other prophylactics that rely on one or two antibodies for protection can develop quickly -and repeatedly- under positive selection.

1 or 2 mutations isn't enough. It would need an order of magnitude more. It's very unlikely for that to happen.

I don't wish to get into a cite duel with what appears to be a Covid troll account.

> 1 or 2 mutations isn't enough.

Enough for what exactly?

> It would need an order of magnitude more. It's very unlikely for that to happen.

Please cite your sources on these points. Otherwise it's just another opinion.

I am not trolling, just genuinely interested in the topic and sick of people spreading misinformation with no citations.

Unless you think trolling is sharing relevant peer-reviewed research that contradicts your unsupported claims.